56-Week Research Trial for Prurigo Nodularis

Adults aged 18 to 80 years old with a diagnosis of prurigo nodularis (PN), with the condition lasting for at least 6 months, may qualify to participate. Individuals must have at least 20 nodules (hard lumps) that are very itchy, present on at least 2 different body locations.

The nodules should be about 0.5 to 2 cm in size.

Participants will receive investigational medication (active study drug) or placebo, via injection (during the double-blind period).In the open-label extension period, all participants will receive active study drug. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 56 weeks and involve about 24 study visits.

Call the study centre near you, or register now.

Learn more about
Prurigo Nodularis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

CA

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more